STOCK TITAN

QT Imaging Holdings Announces $500,000 Insiders PIPE Investment

Rhea-AI Impact
(High)
Rhea-AI Sentiment
(Neutral)
Tags

QT Imaging Holdings (OTCQB:QTIH) has secured a $500,000 PIPE investment from company insiders. Board Chairman Dr. Avi Katz and CEO Dr. Raluca Dinu have agreed to purchase 784,929 unregistered common stock shares at $0.637 per share, representing a 10% premium to the volume weighted average trading price on April 9, 2025.

The deal includes 1,569,858 warrants with an exercise price of $0.72 per share. The financing, expected to close by April 24, 2025, was placed directly by QTI without banking fees. The proceeds will be used as working capital to support the company's business growth.

QT Imaging Holdings (OTCQB:QTIH) ha ottenuto un investimento PIPE di $500.000 da parte di membri interni dell'azienda. Il Presidente del Consiglio Dr. Avi Katz e l'Amministratore Delegato Dr. Raluca Dinu hanno concordato di acquistare 784.929 azioni ordinarie non registrate a $0,637 per azione, rappresentando un premio del 10% rispetto al prezzo medio ponderato per il volume delle negoziazioni del 9 aprile 2025.

Il contratto include 1.569.858 warrant con un prezzo di esercizio di $0,72 per azione. Il finanziamento, previsto per chiudere entro il 24 aprile 2025, è stato effettuato direttamente da QTI senza commissioni bancarie. I proventi saranno utilizzati come capitale di lavoro per supportare la crescita dell'azienda.

QT Imaging Holdings (OTCQB:QTIH) ha asegurado una inversión PIPE de $500,000 de parte de miembros internos de la empresa. El Presidente de la Junta Dr. Avi Katz y la CEO Dr. Raluca Dinu han acordado comprar 784,929 acciones ordinarias no registradas a $0.637 por acción, lo que representa una prima del 10% sobre el precio promedio ponderado por volumen de negociación del 9 de abril de 2025.

El acuerdo incluye 1,569,858 warrants con un precio de ejercicio de $0.72 por acción. El financiamiento, que se espera cierre para el 24 de abril de 2025, fue realizado directamente por QTI sin tarifas bancarias. Los ingresos se utilizarán como capital de trabajo para apoyar el crecimiento del negocio de la empresa.

QT Imaging Holdings (OTCQB:QTIH)는 회사 내부자들로부터 50만 달러의 PIPE 투자를 확보했습니다. 이사회 의장인 Dr. Avi Katz와 CEO인 Dr. Raluca Dinu는 2025년 4월 9일의 거래량 가중 평균 가격에 비해 10% 프리미엄을 나타내는 주당 0.637달러에 등록되지 않은 보통주 784,929주를 구매하기로 합의했습니다.

이번 거래에는 주당 0.72달러의 행사가격을 가진 1,569,858개의 워런트가 포함되어 있습니다. 2025년 4월 24일까지 마감될 것으로 예상되는 이 자금 조달은 QTI가 직접 진행했으며 은행 수수료는 없습니다. 수익금은 회사의 사업 성장을 지원하기 위한 운영 자본으로 사용될 것입니다.

QT Imaging Holdings (OTCQB:QTIH) a sécurisé un investissement PIPE de 500 000 $ de la part d'insiders de l'entreprise. Le Président du Conseil Dr. Avi Katz et la PDG Dr. Raluca Dinu ont convenu d'acheter 784 929 actions ordinaires non enregistrées à 0,637 $ par action, représentant une prime de 10 % par rapport au prix moyen pondéré par le volume de négociation du 9 avril 2025.

L'accord comprend 1 569 858 bons de souscription avec un prix d'exercice de 0,72 $ par action. Le financement, qui devrait être finalisé d'ici le 24 avril 2025, a été réalisé directement par QTI sans frais bancaires. Les produits seront utilisés comme fonds de roulement pour soutenir la croissance de l'entreprise.

QT Imaging Holdings (OTCQB:QTIH) hat eine PIPE-Investition in Höhe von 500.000 USD von Unternehmensinsidern gesichert. Der Vorsitzende des Vorstands Dr. Avi Katz und die CEO Dr. Raluca Dinu haben sich darauf geeinigt, 784.929 nicht registrierte Stammaktien zu einem Preis von 0,637 USD pro Aktie zu kaufen, was einem Aufschlag von 10 % auf den volumen-gewichteten Durchschnittspreis am 9. April 2025 entspricht.

Das Geschäft umfasst 1.569.858 Warrants mit einem Ausübungspreis von 0,72 USD pro Aktie. Die Finanzierung, die voraussichtlich bis zum 24. April 2025 abgeschlossen wird, wurde direkt von QTI ohne Bankgebühren platziert. Die Erlöse werden als Betriebskapital verwendet, um das Unternehmenswachstum zu unterstützen.

Positive
  • Insider investment demonstrates management confidence
  • 10% premium to market price indicates positive valuation outlook
  • No banking fees involved, maximizing capital efficiency
  • Additional working capital secured for business growth
Negative
  • Potential dilution from new share issuance
  • Further dilution possible if warrants are exercised

NOVATO, Calif.--(BUSINESS WIRE)-- QT Imaging Holdings, Inc. (OTCQB:QTIH) a medical device company engaged in research, development, and commercialization of innovative body imaging systems (the “Company”) is pleased to announce an insiders private investment in public equities (PIPE) investment of $500,000 in new funding by the Chairman of the Board, Dr. Avi Katz, and the Chief Executive Officer, Dr. Raluca Dinu. Under the terms of the securities purchase agreement entered into on April 9, 2025, the investors agreed to purchase 784,929 unregistered shares of common stock of the Company at a price of $0.637 per share, together with 1,569,858 warrants with an exercise price of $0.72 per share. The price per share represents a premium of approximately 10% to the Company’s common stock’s volume weighted average trading price on April 9, 2025. The closing of the financing is anticipated to be on or before April 24, 2025, and it was placed directly by QTI, thus it included no associated banking fees. The proceeds are aimed solely at providing working capital for the Company, as it continues to grow its business.

About QT Imaging Holdings, Inc.

QT Imaging Holdings, Inc. is a public (OTCQB: QTIH) medical device company engaged in research, development, and commercialization of innovative body imaging systems using low frequency sound waves. QT Imaging Holdings, Inc. strives to improve global health outcomes. Its strategy is predicated upon the fact that medical imaging is critical to the detection, diagnosis, and treatment of disease and that it should be safe, affordable, accessible, and centered on the patient’s experience. For more information on QT Imaging Holdings, Inc., please visit the company’s website at www.qtimaging.com.

Breast Acoustic CT™ is a trademark of an affiliate of QT Imaging Holdings, Inc.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements contain words such as “will,” and “expect,” or the negative thereof or comparable terminology, and include (without limitation) statements regarding the closing of the PIPE, the intended use of proceeds from the PIPE, the filing of a registration statement covering the resale of the securities being sold, and the Company’s expectations, hopes, beliefs, intentions, plans, prospects or strategies regarding its future business plans. Forward-looking statements involve certain risks and uncertainties, and actual results may differ materially from those discussed in any such statement. These risks include, but are not limited to: research results from the use of the Breast Acoustic CT™ Scanner, the ability of QT Imaging Holdings to sell and deploy the Breast Acoustic CT™ Scanner, the ability to extend product offerings into new areas or products, the ability to commercialize technology, unexpected occurrences that deter the full documentation and “bring to market” plan for products, trends and fluctuations in the industry, changes in demand and purchasing volume of customers, unpredictability of suppliers, the ability to attract and retain qualified personnel and the ability to move product sales to production levels. Additional factors that could cause actual results to differ are discussed under the heading “Risk Factors” and in other sections of QT Imaging Holding’s (and its predecessor, GigCapital5, Inc.) filings with the SEC, and in its other current and periodic reports filed or furnished from time to time with the SEC. All forward-looking statements in this press release are made as of the date hereof, based on information available to QT Imaging Holdings as of the date hereof, and QT Imaging Holdings assumes no obligation to update any forward-looking statement.

For media inquiries, please contact:

Stas Budagov

Chief Financial Officer

Stas.Budagov@qtimaging.com

Source: QT Imaging Holdings, Inc.

FAQ

What is the size and price of QTIH's latest PIPE investment announced in April 2025?

QTIH secured a $500,000 PIPE investment at $0.637 per share, which represents a 10% premium to the stock's volume weighted average trading price.

How many shares and warrants are included in QTIH's April 2025 insider investment?

The investment includes 784,929 unregistered common stock shares and 1,569,858 warrants with a $0.72 exercise price.

When is QTIH's new PIPE investment expected to close?

The financing is anticipated to close on or before April 24, 2025.

Who are the investors in QTIH's April 2025 PIPE financing?

The investors are company insiders: Board Chairman Dr. Avi Katz and CEO Dr. Raluca Dinu.
QT Imaging Holdings

OTC:QTIH

QTIH Rankings

QTIH Latest News

QTIH Stock Data

14.11M
20.75M
25.87%
10.19%
0.97%
Medical Devices
Healthcare
Link
United States
Novato